Delivery Order SPE2DB24D2010-SPE2DB25FZSG7

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with an award value of $1,845.85, is for the delivery of PRIORIX VIALS, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $5,436.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for the procurement of PRIORIX VIALS, a medical product, with a completion date of July 11, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award is a delivery order valued at $17,135.66 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of PRIORIX VIALS, a pharmaceutical product, with a completion date of November 27, 2024. The contract is a firm fixed-price agreement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,664.85 firm fixed-price delivery order is for the supply of PRIORIX VIALS, a medical product, with an ultimate completion date of February 4, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $18,052.30 firm-fixed-price contract is for the supply of PRIORIX VIALS, a vaccine product. The contract has an ultimate completion date of September 4, 2024. AmerisourceBergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of pharmaceutical and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The $24,395.00 firm-fixed-price delivery order is for the supply of PRIORIX VIALS to the agency. The contract has an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of PRIORIX VIALS. The $11,510.43 firm-fixed-price delivery order has an ultimate completion date of February 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of PRIORIX Vials, a pharmaceutical product. The contract has a firm fixed price of $24,395.00 and a period of performance through April 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for...
This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $4,879.00, is for the supply of PRIORIX VIALS, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 7, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds several Indefinite Delivery Contracts...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,758.00 firm fixed price delivery order is for the procurement of PRIORIX VIALS, a pharmaceutical product. The contract has a period of performance through May 17, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB25FZSG7
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,986.68, is for the delivery of PRIORIX Vials, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2024 and is a firm fixed-price type contract.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

This contract award was not designated as a set-aside, indicating open competition. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.

Generated 1/29/25, 9:26 AM